Date Range
Date Range
Date Range
Welcome to Bridge Media Group. Browse or search our product selection to find an extensive range of promotional products. We have a great selection of promotional items. Ranging from low cost to elegant executive gifts. Our wide selection of advertising gifts ensures that you will be able to find exactly what you are looking for to promote your business. Product ranges include promotional keyrings. Trolley Coin Keyring - UK Made - Recycled 709108814.
Phil Mayne
Phil Mayne
Unit 1 Kennet Road
Dartford, Kent, DA1 4QN
GB
Easily Limited
Easily Limited
3rd Floor, Prospero House 241 Borough High St
London, N/A, SE1 1GA
GB
Netnames Ltd
domain Admin
3rd Floor Prospero House 241 Borough High St
London, London, SE1 1GA
GB
Bridge Media Group, LLC, is a Christ-centered marketing, communications, and public relations firm based in Greenville, SC. My niche and passion is working with Christian nonprofit organizations that desire to effectively and efficiently deliver their message for the glory of God. Fill out my online form.
Please contact your service provider for more details.
We create value to viewers allowing them to enjoy a different, interactive and more comprehensive television experience. We create value for channels, content creators, advertisers, developers. allowing new forms of communication solutions. Facilitating a communication oriented to results. One To One Communications allowing every viewer reach the proper content, at the right moment. And gives answers to the demands and habits of a new viewer.
Bridgemedica, LLC is a medical device turnkey concept-to-supply partner, providing a unique single source solution to medical device companies and entrepreneurs alike. Contract Engineering for Medical Devices.
Bridge Medical is a global evidence and outcomes research consulting firm. Since 2011 we have supported many leading pharmaceutical companies to deliver evidence of value to regulators, payers, clinicians and patients across all major therapeutic areas. Together with client colleagues in medical affairs, health outcomes, drug development and epidemiology, our shared goal is to deliver patient access to innovative treatments based on the transparent provision of robust evidence.